Attachment: Nycomed osteoporosis injection system

Nycomed osteoporosis injection syringe - healthcare design

The high cost of a new self-injected osteoporosis pharmaceutical was the focus of a project for Nordic company Nycomed. The aim was to help encourage users to comply, over a lengthy course of self-administered treatment when no immediate improvement would be felt.

Please share...Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInShare on TumblrEmail this to someone